(Q24202832)

PubMed

25 October 2023

Jael Obiero

1

Jael

Obiero

1 reference

PubMed

22696373

25 October 2023

Peter G Mwethera

series ordinal

2

author given names

Peter G

author last names

Mwethera

1 reference

PubMed

22696373

Cochrane Database of Systematic Reviews

25 October 2023

language of work or name

1 reference

13 June 2012

0 references

published in

0 references

cites work

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

SAVVY® (C31G) Gel for prevention of HIV infection in women: a phase 3, double-blind, randomized, placebo-controlled trial in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

A randomized trial of clinician-delivered interventions promoting barrier contraception for sexually transmitted disease prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Use of mandelic acid condensation polymer (SAMMA), a new antimicrobial contraceptive agent, for vaginal prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

GRADE guidelines: 3. Rating the quality of evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Marvellous microbicides. Intravaginal gels could save millions of lives, but first someone has to prove that they work...

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Development of topical microbicides to prevent the sexual transmission of HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Vaginal microbicides and the prevention of HIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Clinical development of microbicides for the prevention of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

The future of HIV microbicides: challenges and opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Inactivation of herpes simplex virus clinical isolates by using a combination microbicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Global control of sexually transmitted infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Challenges in the conduct of vaginal microbicide effectiveness trials in the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Microbicides: a new approach to preventing HIV and other sexually transmitted infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Nonoxynol-9 for preventing vaginal acquisition of HIV infection by women from men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

Personal protection against sexually transmitted diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

7 January 2021

Topical Microbicides for Disease Prevention: Status and Challenges

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

7 January 2021

A pilot study of treatment of bacterial vaginosis with a buffering vaginal microbicide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

7 January 2021

Challenges for the development of female-controlled vaginal microbicides

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

7 January 2021

The contraceptive sponge's protection against Chlamydia trachomatis and Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007961.PUB2

7 January 2021

10.1002/14651858.CD007961.PUB2

Identifiers

DOI

0 references

Fatcat ID

release_j6bkhecehzcjravunmdgnxoyay

0 references